BiomeSense
Dylan is an experienced biomedical engineer with over 7 years experience in product development encompassing a variety of disciplines, including microfluidics, medical devices, and the microbiome. Prior to joining BiomeSense, he helped support and launch Augmenix’s flagship implantable hydrogel product that saw them acquired by Boston Scientific in 2018.